A novel cerebral microangiopathy with endothelial cell atypia and multifocal white matter lesions: A direct mycoplasmal infection?

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 12, 2007, Pages 1100-1117

  Zu Rhein, Gabriele M ^a   Lo, Shyh Ching ^b   Hulette, Christine M ^c   Powers, James M ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Brain endothelium; Immunohistochemistry; Mycoplasma; Myelinated axon; Ultrastructure; Virus

Indexed keywords

ADENOVIRUS; ADULT; ARTICLE; ATAXIA; BACTERIAL INFECTION; BRAIN ATROPHY; BRAIN NECROSIS; CASE REPORT; CELL VACUOLE; CEREBROVASCULAR DISEASE; CYTOMEGALOVIRUS; CYTOPLASM; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DIFFUSE LEWY BODY DISEASE; DYSARTHRIA; DYSPHAGIA; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; JC VIRUS; MALE; MEASLES VIRUS; MICROANGIOPATHY; MYCOPLASMA FERMENTANS; NEUROIMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SPASTICITY; THROMBOCYTE ADHESION; VARICELLA ZOSTER VIRUS; WEAKNESS; WHITE MATTER;

ADULT; AGED; ATROPHY; BRAIN DISEASES; CEREBRAL ANGIOGRAPHY; CEREBRAL CORTEX; ENDOTHELIAL CELLS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MYCOPLASMA INFECTIONS; NEUROGLIA; RETROSPECTIVE STUDIES;

EID: 37349035000     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31815c1e09     Document Type: Article

References (49)

1. Tsiodras S, Kelesidis I, Kelesidis T, et al. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005;51:343-54
2. Behan PO, Feldman RG, Segerra JM, et al. Neurological aspects of mycoplasmal infection. Acta Neurol Scand 1986;74:314-22
3. Tsiodras S, Kelesidis T, Kelesidis I, et al. Mycoplasma pneumoniaea-ssociated myelitis: A comprehensive review. Eur J Neurol 2006;13:112-24
4. Narita M, Itakura O, Matsuzono Y, et al. Analysis of mycoplasmal central nervous system involvement by polymerase chain reaction. Pediatr Infect Dis J 1995;14:236-37
5. Sǒan M, Ravnik I, Benčina D, et al. Neurological symptoms in patients whose cerebrospinal fluid is culture-and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis 2001;32:e31-e35
6. Park BH, Lavi E, Stieber A, et al. Pathogenesis of cerebral infarction and hemorrhage induced by a murine leukemia virus. Lab Invest 1994;71:78-85
7. Wang RY-H, Lo S-C. PCR detection of Myoplasma fermentans infection in blood in urine. In: Persing D, Smith TF, Tenover FC, White TJ, eds. Diagnostic Molecular Microbiology, Principles and Applications. Rochester, MN: American Society for Microbiology, Mayo Foundation, 1993:511-16
8. di Sant'Agnese PA, de Mesy-Jensen KL. Diagnostic electron microscopy on reembedded ("popped off") areas of large Spurr epoxy sections. Ultrastruct Pathol 1984;6:247-53
9. Anders KH, Becker PS, Holden JK, et al. Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: A clinicopathologic review of 16 cases. Hum Pathol 1993;24:897-904
10. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: A hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol 1959;81:154-72
11. Gray F, Bélec L, Chrétien F, et al. Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1998;24:209-16
12. Pennybacker J, Russell DR. Necrosis of the brain due to radiation therapy: Clinical and pathological observations. J Neurol Neurosurg Psychiatry 1948;11:183-98
13. Bruner JM, Tien RD, Thorstad WL. Structural changes produced by intracranial tumors and various forms of antineoplastic therapy. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System. London: Arnold, 1998:2:451-91
14. Zalneraitis EL, Grunnett ML, Quinn JJ, et al. Isolated central nervous system angiopathy associated with busulfan (Abstract). Ann Neurol 1989;26:478
15. Goebel HH, Herman-Ben Zur P. Central pontine myelinolysis: A clinical and pathological study of 10 cases. Brain 1972;95:495-504
16. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979;102:361-85
17. Endo Y, Oda M, Hara M. Central pontine myelinolysis: A study of 37 cases in 1,000 consecutive autopsies. Acta Neuropathol 1981;53:145-53
18. Boon AP, Potter AE. Extensive extrapontine and central pontine myelinolysis associated with correction of profound hyponatraemia. Neuropathol Appl Neurobiol 1987;13:1-9
19. Riggs JE, Schochet SS Jr. Osmotic stress, osmotic myelinolysis, and oligodendrocyte topography. Arch Pathol Lab Med 1989;113:1386-88
20. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: A report of 58 cases. Clin Neuropathol 1987;6:262-70
21. Medana IM, Esiri MM. Axonal damage: A key predictor of outcome in human CNS diseases. Brain 2003;126:515-30
22. Ghosh N, DeLuca GC, Esiri MM. Evidence of axonal damage in human acute demyelinating diseases. J Neurol Sci 2004;222:29-34
23. Kleinschmidt-DeMasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: Then... and now. J Neuropathol Exp Neurol 2006;65:1-11
24. Adams RD, Kubik CS. Subacute degeneration of the brain in pernicious anemia. N Engl J Med 1944;231:1-9
25. Powers JM, Rosenblatt DS, Schmidt RE, et al. Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol 2001;49:396-400
26. de Vries HE, Blom-Rousemalen MCM, van Oosten M, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996;64:37-43
27. Marder VJ, Feinstein DI, Colman RW, et al. Consumptive thrombohemorrhagic disorders. In: Colman RW, Clowes AW, Goldhaber SZ, Marder VJ, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2006:1571-72
28. Chen HC, Hofman FM, Kung JT, et al. Both virus and TNF-α are critical in endothelium damage in a dengue virus-induced hemorrhage mouse model. J Virol 2007;81:5518-26
29. Brenner T, Yamin A, Abramsky O, et al. Stimulation of tumor necrosis factor-α production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res 1993;608:273-79
30. Kita M, Ohmoto Y, Hirai Y, et al. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992;36:507-16
31. Mittelbronn M, Dietz K, Schluesener HJ, et al. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol 2001;101:249-55
32. Case Records of the Massachusetts General Hospital (Case 17-1996). N Engl J Med 1996;334:1461-67
33. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001;345:1250-55
34. Ikeda K, Dörries K, ter Meulen V, et al. Morphological and immunohistochemical studies of the central nervous system involvement in papovavirus K infection in mice. Acta Neuropathol 1988;77:175-81
35. Smith TW, DeGirolami V, Hénin D, et al. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49:357-70
36. Oehlert W. The morphological picture in livers, spleens and lymph nodes of monkeys and guinea pigs after infection with the "Vervet Agent." In: Martini GA, Siegert R. Marburg Virus Disease. New York: Springer Verlag, 1971:150
37. Bellini WJ, Harcourt BH, Bowden N, et al. Nipah virus: An emergent paramyxovirus causing severe encephalitis in humans. J Neurovirol 2005;11:481-87
38. Ho DD, Rota TR, Hirsch MS. Infection of human endothelial cells by human T-lymphotropic virus type 1. Proc Natl Acad Sci USA 1984;81:7588-90
39. Lo SC, Wear DJ, Shih WK, et al. Fatal systemic infections of nonhuman primates by Mycoplasma fermentans (incognitus stain). Clin Infect Dis 1993;17:S283-88
40. Holt SC. Bacteria. In: Johannessen JV, ed. Electron Microscopy in Human Medicine. New York: McGraw-Hill, 1980;3:91-278
41. Willett HP. Mycoplasma. In: Joklik WK, Willett H, Amos DB, Wilfert CM. Zinsser Microbiology. Norwalk, CT: Appleton & Lange, 1992:730
42. Lo SC, Shih JWK, Newton PB III, et al. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am J Trop Med Hyg 1989;41:586-600
43. Zucker-Franklin D, Davidson M, Thomas L. The interaction of mycoplasmas with mammalian cells. I HeLa cells, neutrophils, and eosinophils. J Exp Med 1966;124:521-32
44. Blanchard A, Montagnier L. AIDS-associated mycoplasmas. Annu Rev Microbiol 1998;48:687-712
45. Domermuth CH, Nielsen MH, Freundt EA, et al. Ultrastructure of Mycoplasma species. J Bacteriol 1964;88:727-44
46. Nakamura M, Kawaguchi M. Ultrastructure of Mycoplasma orale serotype 1 in agar growth. J Gen Microbiol 1972;70:305-15
47. Brunner H, Dörner I, Schiefer HG, et al. Lysis of Acholeplasma laidlawii by antibodies and complement. Infect Immunol 1976;13:1671-77
48. Lo SC, Hayes MM, Kotani H, et al. Adhesion onto and invasion into mammalian cells by Mycoplasma penetrans: A newly isolated Mycoplasma from patients with AIDS. Mod Pathol 1993;6:276-80
49. Freundt EA, Vinther O. Mycoplasmas. In: Johannessen JV, ed. Electron Microscopy in Human Medicine. New York: McGraw-Hill, 1980:369-87